Kangshun Zhu, MD
Second Affiliated Hospital of Guangzhou Medical University
4
2
1
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yefa Yang, MD
Eastern Hepatobiliary Surgery Hospital
Shared therapeutic areas:
Worked with same sponsors:
Xiaobin Feng, MD
Beijing Tsinghua Changgeng Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jinbo Yue, Doctor
Shandong Cancer Hospital and Institute
Shared therapeutic areas:
Saleh K Saleh, MD
Minia University
Shared therapeutic areas:
Ping Liang, doctor
Chinese PLA General Hospital
Shared therapeutic areas:
Ajay Goel, PhD
City of Hope Medical Center
Shared therapeutic areas:
Tim F Greten, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Salah-Eddin Al-Batran, Prof. Dr.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Shared therapeutic areas:
Vincent Chung
City of Hope Medical Center
Shared therapeutic areas:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC
HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT
TACE Combined With Iodine-125 Seeds Implantation for HCC
All 4 trials loaded